Rss Feed

Subscribe to Rss Feed feed
Latest Medical Research News and Research
Updated: 12 min 55 sec ago

Researchers identify a compound that inhibits growth of schwannomas

Mon, 09/21/2020 - 18:27
Schwannomas are tumors of the peripheral nervous system, which often occur in the genetic disease neurofibromatosis type 2. The research group of Prof. Dr. Helen Morrison at the Leibniz Institute on Aging - Fritz Lipmann Institute in Jena, Germany, identified a compound that inhibits the growth of such tumors and improves nerve function.

Providing personalized care for bleeding disorders

Mon, 09/21/2020 - 13:53
An interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.

Awareness of erectile dysfunction is alarmingly low in men and women

Mon, 09/21/2020 - 11:45
Awareness of erectile dysfunction (ED) is alarmingly low in men and women aged 20 to 70, a new survey commissioned by the European Association of Urology (EAU) has revealed.

CDC updates coronavirus guidelines to recognize airborne spread

Mon, 09/21/2020 - 11:44
Early on in the pandemic, it was thought that the virus was only spread via respiratory droplets. However, scientific research soon showed it also to be an airborne virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) has updated its guideline, acknowledging that the virus can hang in the air, fueling its spread.

Researchers analyze kits to detect and inactivate COVID-19

Mon, 09/21/2020 - 11:36
The nation's ability to test for COVID-19 has expanded, thanks to work at the U.S. Department of Energy's Pacific Northwest National Laboratory in collaboration with the University of Washington.

Black women experience longer waits for treatment after breast cancer diagnosis, indicates study

Mon, 09/21/2020 - 11:11
New research suggests that Black women experience longer waits for treatment initiation than white women after a breast cancer diagnosis, and their duration of treatment is prolonged.

Type 1 diabetes is associated with increased risk of falls

Mon, 09/21/2020 - 11:04
New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year (21-25 September), shows that having type 1 diabetes (T1D) is associated with a 33% increase in the risk of falls compared with the general population, while having type 2 diabetes (T2D) is associated with a 19% increased risk of falls.

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

Mon, 09/21/2020 - 11:03
A new study by researchers at NYU Langone Medical Center and Weill Cornell Medical College and published on the preprint server bioRxiv* in September 2020 reports the potential of an angiotensin-converting enzyme 2 (ACE2)-antibody Fc complex in a new format that seems to offer more significant inhibition of SARS-CoV-2.

Rheumatoid arthritis is associated with increased risk of developing diabetes

Mon, 09/21/2020 - 10:56
A new study presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that rheumatoid arthritis (RA) is associated with a 23% increased risk of type 2 diabetes (T2D), and may indicate that both diseases are linked to the body's inflammatory response.

Study: Greater exercise capacity is linked to decreased mortality risk in people with type 2 diabetes

Mon, 09/21/2020 - 10:54
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that having a greater exercise capacity is associated with a significantly decreased all-cause mortality risk of between 25-33% in people with type 2 diabetes (T2D).

New study identifies more than 2,000 undiagnosed cases of type 2 diabetes

Mon, 09/21/2020 - 10:52
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.

PROfound phase III results offer new targeted treatment for metastatic prostate cancer

Mon, 09/21/2020 - 10:48
Results from the PROfound phase III study, funded by AstraZeneca and Merck Sharp & Dohme, open up a much-needed new treatment avenue for the more precise and effective treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) whose disease has progressed with hormonal therapy.

Post-operative radiotherapy in NSCLC shows no statistically difference in 3-year disease-free survival

Mon, 09/21/2020 - 10:44
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.

Adding abemaciclib to hormonal therapy reduces recurrence in patients with HR+ HER2- early breast cancer

Mon, 09/21/2020 - 10:35
Adding abemaciclib to hormonal therapy reduces the risk of cancer recurrence by 25% in patients with high-risk early hormone receptor positive (HR+) human epidermal growth factor receptor 2 negative (HER2-) breast cancer, according to results from a study at ESMO 2020.

Researchers assess similarity of couples in pathophysiological mechanisms of type 2 diabetes

Mon, 09/21/2020 - 10:27
New research being presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year, shows that when one half of a couple shows high levels of certain behaviours that prevent type 2 diabetes, such as good diet or exercise, that behaviour also tends to be high in the other half of the couple.

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

Mon, 09/21/2020 - 09:50
A recent study published on the preprint server bioRxiv* seeks to establish the pattern of antibody reactivity in COVID-19 convalescent plasma (CCP), which is widely being used as a therapy for seriously ill COVID-19 patients.

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Mon, 09/21/2020 - 09:25
A recent study published on the preprint server bioRxiv* in September 2020 shows the value of drug combinations to enhance the therapeutic and preventive efficacy of such repositioned drugs in standard antiviral therapy.

Chinese workers knowledge, attitudes and practices regarding COVID-19

Mon, 09/21/2020 - 08:47
In new research, scientists in China have looked at the knowledge, attitudes, and practices regarding COVID-19 among Chinese workers. The research paper titled, “Knowledge, attitudes, and practices related to Coronavirus disease 2019 during the outbreak among workers in China: A large cross-sectional study,” is published in the latest issue of the journal PLOS Neglected Tropical Diseases.

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

Mon, 09/21/2020 - 08:15
A team of researchers from Aix-Marseille Univ, IHU-Méditerranée Infection, Institut Paoli Calmettes and Laboratoire d’Immunologie, Marseille, France, conducted experiments to determine if SARS-CoV-2 can affect the myeloid compartment or infect monocytes and macrophages.

Scientists investigate active plasma metabolite of remdesivir in SARS-CoV-2 mouse model

Mon, 09/21/2020 - 05:23
Using mouse models, scientists have investigated the active plasma metabolite of remdesivir, GS-441 524, and hydroxychloroquine as possible drug candidates in COVID-19. The research shows GS-441 524 could be an effective therapeutic drug against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while at the same time discounting hydroxychloroquine as a reliable anti-viral.

Pages